Grants and Contributions:
Title:
Development and optimization of bioinformatics-based evaluation technologies for the measurement of changes in immune repertoire
Agreement Number:
963057
Agreement Value:
$36,420.00
Agreement Date:
Jan 4, 2021 - Nov 30, 2021
Description:
The project involves developing computational methods to measure changes in the repertoire of lymphocyte receptors critical for adaptive immunity. These methods will help measure the impact of Immunoflex products.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
West Vancouver, British Columbia, CA V7W 1K3
Reference Number:
172-2020-2021-Q4-963057
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
733478275
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 153 days.
Amendment Date
Jun 24, 2021
Recipient's Legal Name:
ImmunoFlex Therapeutics Inc.
Federal Riding Name:
West Vancouver--Sunshine Coast--Sea to Sky Country
Federal Riding Number:
59042
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: